COVID-19: Surge in the use of NHS tech in 2020
Ben Davison, NHS Digital’s Executive Director for Product Development, explains how the coronavirus pandemic prompts a surge in the number of people using NHS tech in 2020.
Can pubs effectively prevent COVID-19 transmission risk?
A new study has questioned whether pub operators can effectively and consistently prevent COVID-19 transmission risk.
How TECS have supported the NHS pre, during and post-COVID
Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.
Heart failure drug may treat COVID-19 long-hauler symptom
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
Covax will protect millions of Pakistanis against COVID-19
The global vaccine facility Covax will help Pakistan’s vaccination programme protect millions of Pakistanis against COVID-19.
How patients can overcome needle phobia and get the COVID vaccine
Dr Deborah Lee, Dr Fox Online Pharmacy, explores what can be done to help patients who refuse the COVID-19 vaccination due to needle phobia.
What are the side effects of the AstraZeneca vaccine?
Here, we use science to dissect some of the rumours about the side effects of the AstraZeneca and Oxford University vaccine.
Tocilizumab reduces deaths in hospitalised COVID-19 patients
A new trial has found that tocilizumab, an anti-inflammatory treatment, reduces the risk of death in patients hospitalised with COVID-19.
Scientists suggest that former President Trump caused 461,000 excess deaths
The Lancet report is out today (11 February), which suggests that former President Trump's policymaking created an excess of "461,100 deaths" - before the COVID-19 pandemic hit the United States.
Supporting vaccination campaigns through high-quality cold storage solutions
Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.
New white paper will give Government more control over NHS
The legislative changes in the white paper released today (11 February) include giving local and central Government more control over the NHS - which is expected to be implemented in 2022.
COVID-19: The truth about super-spreaders
Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the truth about super-spreaders as part of our focus on COVID-19.
WHO recommends use of AstraZeneca vaccine for all age groups
The World Health Organisation have suggested that the Oxford and AstraZeneca vaccine can be safely used for all age groups, including those aged 65 and over.
People with obesity nearly three times as likely to get Type 2 diabetes
New research by the American Heart Association finds that obesity is a factor in almost half of all new cases, with obese individuals significantly more likely to get Type 2 diabetes.
Oral health and restorative dentistry
Karlo Jacutan, on behalf of Dental Arch, comments on the importance of promoting oral health among populations during the COVID-19 pandemic and restorative dentistry.
Unpaid carers will have access to free PPE through national scheme
Unpaid carers will now benefit from free Personal Protective Equipment (PPE) through a new national scheme, the UK government has announced.
The science and art of dispensing optics
The science and art of dispensing optics are ever dynamic, writes Daryl Newsome from the Association of British Dispensing Opticians. Opticians must adopt new technology, adapt their practice of dispensing and take ownership of innovation, he argues.
COVID-19: The challenge of healthcare logistics
Zisis Kozlakidis, International Agency for Research on Cancer, with Erik Steinfelder, Thermo Fisher Scientific, chart the challenges in healthcare logistics in relation to COVID-19.
AstraZeneca vaccine cannot stop the South African mutation
The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.
UK Government and CureVac partnership to tackle COVID-19 virus variants
The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
